ea0083erco1 | Endocrine-related Cancer | EYES2022
A. J. Montero-Hidalgo
, P. Saez-Martinez
, A. Sarmento-Cabral
, A. S. De la Rosa-Herencia
, R. Sanchez-Sanchez
, T. Gonzalez-Serrano
, E. Gomez-Gomez
, M. D. Gahete
, R. M. Luque
, J. M. Jimenez-Vacas
Background: Prostate cancer (PCa) is one the leading causes of cancer-related deaths among men in developed countries. Therefore, the identification of novel molecular targets for treatment is urgently needed to improve patientsÂ’ outcomes. In this scenario, our group has recently reported that elements of the cellular machinery controlling alternative-splicing processes might be used as potential novel therapeutic tools for PCa. In this context, although RBM22 has been id...